Daybue

Active Ingredient(s): Trofinetide
FDA Approved: * March 10, 2023
Pharm Company: * ACADIA PHARMS INC
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Daybue 200 mg/ml Oral Solution
NDC: 63090-660
Labeler:
Acadia Pharmaceuticals Inc.